{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:20:19Z","timestamp":1790508019032,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.kint.2024.01.030","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T09:08:42Z","timestamp":1713431322000},"page":"932-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-6005","authenticated-orcid":false,"given":"Eugene Yu-hin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-1359","authenticated-orcid":false,"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.01.030_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(23)01051-6","article-title":"Childhood nephrotic syndrome","volume":"402","author":"Vivarelli","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2024.01.030_bib2","first-page":"1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","author":"Trautmann","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.01.030_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","article-title":"A\u00a0randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome","volume":"93","author":"Gruppen","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.030_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","article-title":"Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"95","author":"Sinha","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.030_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.kint.2024.01.028","article-title":"An open label non-inferiority randomized controlled trial evaluated alernate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome","volume":"105","author":"Sinha","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.030_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.01.030_bib7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/ph16060846","article-title":"Pulmonary-renal syndrome from levamisole-adulterated cocaine-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a systematic review","volume":"16","author":"Bucur","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.kint.2024.01.030_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1046\/j.1365-2133.1999.02833.x","article-title":"Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children","volume":"140","author":"Rongioletti","year":"1999","journal-title":"Br J Dermatol"},{"issue":"suppl 3","key":"10.1016\/j.kint.2024.01.030_bib9","first-page":"gfac103","article-title":"FC038: efficacy of levamisole for maintaining remission after the first flare of steroid sensitive nephrotic syndrome in children: the Nephrovir-3 randomized controlled trial","volume":"37","author":"Dossier","year":"2022","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T03:20:51Z","timestamp":1716261651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0085253824000954"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.030","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}